2026 is shaping up to be a strong year to do deals, but not an easy one. Activity is picking up, lenders are more open for business, and sellers are coming back to market. At the same time, buyers are far less forgiving of loose stories and half-baked growth plans. The deals getting done are the ones with a clear operating angle, not just a financial one. In the middle market, platform builds, PPM roll-ups, and smart bolt-on strategies are leading the charge. Buyers are spending more time underwriting integration, physician alignment, and post-close execution than they are debating headline multiples. The question we hear most often is no longer, “Can we buy this asset,” but, “Can we actually run it better once we own it?”
Read the full article: 2026 Healthcare M&A: What’s Changed, What’s Working, and Where Deals Are Moving //
Source: https://www.jdsupra.com/legalnews/2026-healthcare-m-a-what-s-changed-what-3351490/